Congrats to Horizon Pharma (HZNP) and especially patients with thyroid eye disease (TED), on the positive phase 3 results reported...

Looking forward to Global Blood Therapeutics report out of Part A from their Phase 3 Hope study of their drug voxelotor (formerly GBT440)...